Sika Valuation

Is 0Z4C undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0Z4C when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
CHF 223.40
Fair Value
1.3% undervalued intrinsic discount
21
Number of Analysts

Below Fair Value: 0Z4C (CHF220.54) is trading below our estimate of fair value (CHF223.4)

Significantly Below Fair Value: 0Z4C is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0Z4C?

Key metric: As 0Z4C is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0Z4C. This is calculated by dividing 0Z4C's market cap by their current earnings.
What is 0Z4C's PE Ratio?
PE Ratio28x
EarningsCHF 1.25b
Market CapCHF 34.97b

Price to Earnings Ratio vs Peers

How does 0Z4C's PE Ratio compare to its peers?

The above table shows the PE ratio for 0Z4C vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.3x
CRDA Croda International
27.5x15.3%UK£4.5b
JMAT Johnson Matthey
4.1x-24.7%UK£2.2b
VCT Victrex
51x29.3%UK£876.8m
TET Treatt
18.5x10.3%UK£266.4m
0Z4C Sika
28x7.8%CHF 35.0b

Price-To-Earnings vs Peers: 0Z4C is expensive based on its Price-To-Earnings Ratio (28x) compared to the peer average (25.3x).


Price to Earnings Ratio vs Industry

How does 0Z4C's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
0Z4C 28.0xIndustry Avg. 17.2xNo. of Companies11PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0Z4C is expensive based on its Price-To-Earnings Ratio (28x) compared to the European Chemicals industry average (17.2x).


Price to Earnings Ratio vs Fair Ratio

What is 0Z4C's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0Z4C PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio28x
Fair PE Ratio18.8x

Price-To-Earnings vs Fair Ratio: 0Z4C is expensive based on its Price-To-Earnings Ratio (28x) compared to the estimated Fair Price-To-Earnings Ratio (18.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0Z4C forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 220.54
CHF 275.55
+24.9%
15.3%CHF 350.00CHF 209.00n/a21
Jan ’26CHF 215.80
CHF 281.40
+30.4%
14.5%CHF 350.00CHF 209.00n/a21
Dec ’25CHF 228.30
CHF 288.67
+26.4%
11.9%CHF 350.00CHF 220.00n/a21
Nov ’25CHF 242.69
CHF 291.76
+20.2%
13.0%CHF 370.00CHF 220.00n/a21
Oct ’25CHF 280.84
CHF 298.48
+6.3%
12.4%CHF 370.00CHF 230.00n/a21
Sep ’25CHF 272.00
CHF 296.00
+8.8%
12.8%CHF 380.00CHF 230.00n/a22
Aug ’25CHF 266.80
CHF 295.00
+10.6%
13.0%CHF 380.00CHF 230.00n/a22
Jul ’25CHF 255.38
CHF 295.68
+15.8%
12.8%CHF 380.00CHF 230.00n/a22
Jun ’25CHF 275.08
CHF 294.48
+7.1%
13.1%CHF 380.00CHF 230.00n/a21
May ’25CHF 263.30
CHF 293.76
+11.6%
13.2%CHF 380.00CHF 230.00n/a21
Apr ’25CHF 268.64
CHF 290.85
+8.3%
14.6%CHF 390.00CHF 224.00n/a20
Mar ’25CHF 257.53
CHF 288.19
+11.9%
14.5%CHF 390.00CHF 224.00n/a21
Feb ’25CHF 239.96
CHF 285.10
+18.8%
15.2%CHF 390.00CHF 230.00n/a21
Jan ’25CHF 273.60
CHF 283.19
+3.5%
16.1%CHF 380.00CHF 225.00CHF 215.8021
Dec ’24CHF 236.15
CHF 281.10
+19.0%
16.6%CHF 380.00CHF 223.00CHF 228.3021
Nov ’24CHF 215.20
CHF 282.43
+31.2%
16.2%CHF 380.00CHF 223.00CHF 242.6921
Oct ’24CHF 234.10
CHF 298.50
+27.5%
12.9%CHF 380.00CHF 230.00CHF 280.8421
Sep ’24CHF 247.34
CHF 300.09
+21.3%
13.0%CHF 380.00CHF 228.00CHF 272.0022
Aug ’24CHF 270.73
CHF 300.00
+10.8%
13.8%CHF 390.00CHF 228.00CHF 266.8021
Jul ’24CHF 248.50
CHF 304.05
+22.4%
14.8%CHF 390.00CHF 228.00CHF 255.3821
Jun ’24CHF 248.49
CHF 298.88
+20.3%
14.3%CHF 390.00CHF 228.00CHF 275.0821
May ’24CHF 244.27
CHF 295.43
+20.9%
14.3%CHF 390.00CHF 228.00CHF 263.3020
Apr ’24CHF 251.01
CHF 293.95
+17.1%
17.3%CHF 390.00CHF 162.95CHF 268.6422
Mar ’24CHF 262.20
CHF 292.13
+11.4%
17.6%CHF 390.00CHF 162.95CHF 257.5322
Feb ’24CHF 261.91
CHF 277.59
+6.0%
16.4%CHF 380.00CHF 162.95CHF 239.9622
Jan ’24CHF 222.68
CHF 280.81
+26.1%
20.0%CHF 420.00CHF 162.95CHF 273.6021
Analyst Price Target
Consensus Narrative from 21 Analysts
CHF 278.76
Fair Value
20.9% undervalued intrinsic discount
21
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/11 15:31
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sika AG is covered by 42 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Félix BrunotteAlphaValue
Volker BosseBaader Helvea Equity Research
Zana MamelliBaader Helvea Equity Research